Intratumoral Cancer Therapies Market Current Scenario Trends, Comprehensive Analysis and Regional Forecast 2023 to 2032

0
541

A recently published study by FMI expects the global Intratumoral Cancer Therapies market to garner a market value of US$ 212.96 Billion in 2023 and is expected to accumulate a market value of US$ 552.36 Billion by registering a CAGR of 10% in the forecast period 2023-2033.

Growth of the Intratumoral Cancer Therapies market can be attributed to favorable regulatory frameworks for cancer treatments. The market for Intratumoral Cancer Therapies registered a CAGR of 7% in the historical period 2017-2022.

The growth is attributed to the increasing prevalence of cancer cases, pushing the regulatory bodies to work on research and development. For instance, in September 2022, the Hadassah Cancer Research Institute (HCRI), Jerusalem declared that it will lead the CancerRNA, a global forum working towards development and application of RNA-based immunotherapy to effectively utilize anti-cancer immune responses.

Request for a sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-16153

In terms of market share and revenue, the North American market is predicted to be the most lucrative market during the forecast period with a revenue share of 40%. The region’s growth is driven by the presence of various biotechnology and medical device firms. For instance, in March 2020, Johnson and Johnson received the US FDA Breakthrough Therapy Designation for JNJ-61186372 (JNJ-6372) for the treatment of patients with metastatic non-small cell lung cancer (NSCLC).

Key Takeaways from the Market Study

  • From 2017-2022, the Intratumoral Cancer Therapies market grew at CAGR of 7%.
  • The global Intratumoral Cancer Therapies market is expected to grow with a 10% CAGR during 2023-2033.
  • As of 2033, the Intratumoral Cancer Therapies market is expected to reach US$ 552.36 Billion.
  • Checkpoint inhibitors segment is poised to register the highest growth rate through 2033.
  • North America is expected to possess 40% market share for Intratumoral Cancer Therapies market in North America.
  • The European market is predicted to increase significantly throughout the forecast period, with a CAGR of 5% during the forecast period.
  • By application, lung cancer is estimated to account for the largest share of the market.

Ask A Question @ https://www.futuremarketinsights.com/ask-question/rep-gb-16153

“Cancer is among the top causes of mortality worldwide, and its incidence is increasing at an alarming rate. As a result, healthcare experts are concentrating on the development of efficient treatment and diagnosis solutions in order to reduce the incidence level.” says an FMI analyst

Market Competition

Key players in the Intratumoral Cancer Therapies market are Amgen Inc, AstraZeneca, Bayer AG, Bristol-Myers Squibb Company, Pfizer Inc, Novarts AG, Johnson & Johnson, and Eli Lily Company, F.

  • Gland Pharma has launched the cancer treatment medicine Bortezomib for Injection in the United States in 2022. The drug business stated in a statement that it has released the medicine in the US market through a partner who has acquired permission from the US Food and Drug Administration (USFDA). The business claims that its medicine is medically similar to Velcade for Injection from Takeda Pharmaceuticals. Bortezomib for Intravenous is used to treat cancers such as myeloma and mantle cell lymphoma.

Key Segments Profiled in the Intratumoral Cancer Therapies Industry Survey

Technology:

  • Monoclonal Antibodies
  • Vaccines
  • Checkpoint Inhibitors
  • Cell Therapies
  • Immune System Modulators
  • Adoptive Cell Transfer
  • Cytokines

Application:

  • Lung Cancer
  • Breast Cancer
  • Melanoma
  • Prostate Cancer
  • Head & Neck Cancer
  • Others

End-users:

  • Hospitals
  • Cancer Research Centres
  • Clinics

Full Report @ https://www.futuremarketinsights.com/reports/intratumoral-cancer-therapies-market

 

Zoeken
Categorieën
Read More
Health
Negative Pressure Wound Therapy Market in-Depth Analysis, Growth, Size, Future Prospect, Regional Development and Global Outlook 2022 to 2032
The Negative Pressure Wound Therapy (NPWT) Market was valued at US$ 5.9 billion in 2021 and is...
By Sanket Badgujar 2023-05-16 07:45:50 0 471
Other
Potato Starch Market , trends, share, value ,industry size, growth, opportunities and forecast by 2029 bicycle frame
The reliable Potato Starch Market business report presents major product developments and...
By Prachi Kolhe 2024-04-08 09:26:14 0 160
Other
Die Vorteile der Zusammenarbeit mit einer Agentur Managed Server Provider
In der heutigen digitalen Welt ist die Verfügbarkeit einer zuverlässigen und...
By Onyx Hostingde 2023-07-07 13:18:46 0 627
Other
Bulk Sweeteners, Big Savings: Discovering the Sweet Side of 
  Are you a fan of delicious treats and sweet delights but concerned about the impact of...
By Rosarioalivia Rosarioalivia 2024-02-21 15:23:48 0 229
Other
Professional Bathroom Renovations in Penrith | Experienced Contractors
Get your dream bathroom with the help of the experienced team at Penrith bathroom renovations. We...
By Nemfel Group 2023-04-25 12:49:23 0 636